8月7日 - ** 制药公司Iovance Biotherapeutics IOVA.O股价在延时交易中下跌30.7%，至1.83美元。
** 根据LSEG汇编的数据，该公司公布的 (link)，第二季度营收为6000万美元，低于分析师平均预期的6979万美元。
** 第二季度亏损 33 美分，分析师预期亏损 28 美分
** 公司称将在今年第三季度前裁员 19
** IOVA 重申产品总收入指导范围为 2.5 亿至 3 亿美元，预期为 3.0018 亿美元。
** 今年以来股价下跌 64.3
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.